Massachusetts General Hospital. Psicofarmacología y Neuroterapéutica
- 2nd Edition - October 6, 2025
- Latest edition
- Authors: Theodore A. Stern, Joan A. Camprodon, Maurizio Fava
- Language: Spanish
Información práctica y específica de uno de los principales hospitales y departamentos de psiquiatría del mundo. La segunda edición de Massachusetts General Hospital. Psicofarma… Read more
Purchase options
Información práctica y específica de uno de los principales hospitales y departamentos de psiquiatría del mundo.
La segunda edición de Massachusetts General Hospital. Psicofarmacología y Neuroterapéutica es la guía ideal sobre los más actuales tratamientos psicofarmacológicos y somáticos para enfermedades psiquiátricas y neurológicas. Compuesta por capítulos extraídos principalmente de la tercera edición de Massachusetts General Hospital. Tratado de Psiquiatría Clínica, de Stern et al., la presente obra, exhaustivamente revisada, se centra en los tratamientos psicotrópicos actuales, la terapia electroconvulsiva y la neuroterapéutica, lo que la convierte en una herramienta de ágil consulta, ideal para psiquiatras, psicólogos, internistas y enfermeras.
- Ofrece información actualizada sobre temas clave como la utilización de antiepilépticos, ansiolíticos, estabilizadores del ánimo y psicoestimulantes; interacciones entre fármacos; efectos secundarios; adherencia al tratamiento, etc.
- Aborda detalladamente antidepresivos, antipsicóticos y ansiolíticos, y expone los avances alcanzados en el cuidado de pacientes con depresión resistente al tratamiento, asi como las nuevas consideraciones legales a la hora de prescribir psicotrópicos.
- Cubre los avances recientes en el uso de intervenciones neuroterapéuticas, como la estimulación magnética transcraneal, la estimulación del nervio vago y la estimulación cerebral profunda.
- Contiene un nuevo capítulo sobre la farmacoterapia de los trastornos del movimiento (derivado de Massachusetts General Hospital. Handbook of General Hospital Psychiatry, 8th edition, de Stern et al.).
- Presenta un formato sistemáticamente estructurado y fácil de usar, con abundantes resúmenes en forma de cuadros, listados de puntos clave y referencias bibliográficas.
- Ofrece criterios actualizados del DSM-5-TR®, asi como prácticos y valiosos consejos de los miembros del Departamento de Psiquiatría del Massachusetts General Hospital.
- Versión ebook del libro incluida con la compra. El ebook permite acceder a todo el texto, las figuras y las referencias bibliográficas, asi como hacer búsquedas, anotaciones y resaltados, y reproducir el contenido en audio (contenidos íntegramente en inglés).
1. Neurociencia psiquiátrica: inclusión de la fisiopatología en la formulación de casos clínicos. 2. Adherencia al tratamiento. 3. Abordajes farmacológicos de la depresión y la depresión resistente al tratamiento. 4. El litio y su función en psiquiatría. 5. Uso de f'armacos antiepilépticos en psiquiatría. 6. Farmacoterapia de los trastornos de ansiedad. 7. Farmacoterapia del trastorno por déficit de atención con hiperactividad a lo largo de la vida. 8. Fármacos naturales en psiquiatría. 9. Antipsicóticos. 10. Pacientes con movimientos anómalos. 11. Fisiopatología, comorbilidad psiquiátrica y tratamiento del dolor. 12. Enfermedades psiquiátricas durante el embarazo y el puerperio. 13. Efectos secundarios de los psicofármacos. 14. Interacciones farmacológicas en psicofarmacología. 15. Farmacoterapia de los trastornos neurocognitivos y la demencia. 16. Farmacoterpai de los trastornos por consumo de sustancias. 17. Farmacoterapia de los trastornos sexuales y la disfunción sexual. 18. Terapias de neuromodulación con dispositivos y de estimulación cerebral. 19. Consideraciones jurídicas para los profesionales de servicios de de sald mental. Índice alfabético.
- Edition: 2
- Latest edition
- Published: October 6, 2025
- Language: Spanish
TS
Theodore A. Stern
Dr. Theodore A. Stern is the Ned H. Cassem Professor of Psychiatry in the field of Psychosomatic Medicine/Consultation at Harvard Medical School (HMS), Chief Emeritus of The Avery D. Weisman, Psychiatry Consultation Service, and Director of the Thomas P. Hackett Center for Scholarship in Psychosomatic Medicine at the Massachusetts General Hospital (MGH). Dr. Stern has co-authored more than 550 peer-reviewed journal articles and book chapters, and he has edited or authored more than 60 books (including the MGH Handbook of General Hospital Psychiatry, the MGH Psychiatry Update and Board Preparation, Learning About Psychopharmacology, Facing Overweight and Obesity, Facing Pelvic Pain, Facing Memory Loss and Dementia, Facing Serious Mental Illness, and the MGH Study Guide for Psychiatry Exams). Dr. Stern is a Past-President of the Academy of Consultation-Liaison Psychiatry (ACLP) and is the Editor-in-Chief Emeritus of its journal, Psychosomatics (now called Journal of the Academy of Consultation-Liaison Psychiatry). He has won the coveted “Best Teacher Award” from the graduating residents at the MGH/McLean Hospital Psychiatric Residency Training Program, the Cynthia N. Kettyle Teaching Award from the HMS Department of Psychiatry, the MGH Department of Psychiatry’s Award for Exceptional Mentorship in the Clinical Realm, a Lifetime Achievement Award from the Society of Liaison Psychiatry, and the Thomas P. Hackett Award from the ACLP (its highest honor).
Affiliations and expertise
Psychiatrist and Chief Emeritus, Avery D. Weisman Psychiatry Consultation Service, Director, Thomas P. Hackett Center for Scholarship in Psychosomatic Medicine, Massachusetts General Hospital, Boston, MA, USA, Ned H. Cassem Professor of Psychiatry in the Field, Psychosomatic Medicine/Consultation, Harvard Medical School, Boston, MA, USAJC
Joan A. Camprodon
Dr. Joan A. Camprodon is board-certified in Psychiatry, and Behavioral Neurology & Neuropsychiatry. His research (as Director of the Laboratory for Neuropsychiatry and Neuromodulation) uses multimodal combinations of neuroimaging and brain stimulation to investigate neural circuitry and plasticity in a translational manner. His lab works with a wide range of noninvasive and invasive neuromodulation techniques including transcranial electrical current stimulation (tECS), transcranial magnetic stimulation (TMS), electroconvulsive therapy (ECT) and deep brain stimulation (DBS) among others. The scope of his research includes basic, translational and clinical projects focused on circuit neuroscience.
Affiliations and expertise
Chief, Division of Neuropsychiatry, Massachusetts General Hospital, Director, Laboratory for Circuit Neuroscience and Neuromodulation, Massachusetts General Hospital, Director, Transcranial Magnetic Stimulation Clinical Service, Psychiatry, Massachusetts General Hospital, Boston, MA, USA, Associate Professor of Psychiatry, Harvard Medical School, Boston, MA, USAMF
Maurizio Fava
Dr. Maurizio Fava is Chair of the Department of Psychiatry at the Massachusetts General Hospital (MGH). Dr. Fava obtained his MD from University of Padova School of Medicine (residency in endocrinology); he completed residency training in psychiatry at the MGH. He founded and was director of the hospital’s Depression Clinical and Research Program (DCRP) from 1990 to 2014. In 2007, he founded and is now Executive Director of the MGH Clinical Trials Network and Institute (CTNI), the first academic CRO specialized in planning and coordination of multi-center clinical trials in psychiatry. Under Dr. Fava’s direction, the DCRP became one of the most highly regarded depression programs in the country, a model for academic programs that link, in a bi-directional fashion, clinical and research work. His prominence in the field is reflected in his role as the co-principal investigator of STAR*D, the largest research study ever conducted in the area of depression, and of the RAPID Network, the NIMH-funded series of studies of novel, rapidly acting antidepressant therapies. Dr. Fava is a world leader in the field of depression. He has authored or co-authored more than 900 original articles published in medical journals with international circulation, edited eight books, and has been successful in obtaining funding as principal or co-principal investigator from both the National Institutes of Health and other sources for a total of more than $150 million.
Affiliations and expertise
Psychiatrist-in-Chief, Department of Psychiatry, Vice Chair, Executive Committee on Research, Massachusetts General Hospital, Boston, MA, USA, Executive Director, Clinical Trials Network & Institute (CTNI), Massachusetts General Hospital, Boston, MA, USA, Associate Dean for Clinical & Translational Research & Slater Family Professor of Psychiatry, Harvard Medical School, Boston, MA, USA